OccuRx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

OccuRx General Information

Description

Developer of therapeutic strategies designed to aid in the treatment of disorders associated with retinal fibrosis. The company's strategies offer proprietary small-molecule drugs to address the unmet clinical need for targeted ocular therapies to enhance visual acuity and prevent vision loss in inflammatory and degenerative eye diseases, enabling healthcare professionals to prevent the growth of new and abnormal blood vessels and reduce inflammation of the neurons in the retina.

Contact Information

Website
www.occurx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 31 Queen Street
  • Level 9
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • 31 Queen Street
  • Level 9
  • Melbourne, Victoria 3000
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OccuRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 19-Dec-2024 Completed Generating Revenue
6. Later Stage VC 05-Sep-2022 Completed Clinical Trials - Phase 2
5. Grant 20-Jul-2022 Completed Clinical Trials - Phase 2
4. Later Stage VC 01-Jan-2020 Completed Clinical Trials - Phase 2
3. Later Stage VC 01-Jan-2019 Completed Clinical Trials - Phase 2
2. Seed Round 19-May-2015 $5.13M $5.13M Completed Startup
1. Angel (individual) Completed Startup
To view OccuRx’s complete valuation and funding history, request access »

OccuRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic strategies designed to aid in the treatment of disorders associated with retinal fibrosis. The
Biotechnology
Melbourne, Australia
5 As of 2021

Alpharetta, GA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OccuRx Competitors (9)

One of OccuRx’s 9 competitors is Clearside Biomedical, a Formerly VC-backed company based in Alpharetta, GA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clearside Biomedical Formerly VC-backed Alpharetta, GA
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
Beacon Therapeutics Venture Capital-Backed Alachua, FL
Gradalis Private Equity-Backed Carrollton, TX
Rein Therapeutics Formerly VC-backed Austin, TX
You’re viewing 5 of 9 competitors. Get the full list »

OccuRx Patents

OccuRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4308541-A1 Compounds for the treatment of disorders and salts and polymorphs thereof Pending 17-Mar-2021
CA-3213293-A1 Compounds for the treatment of disorders and salts and polymorphs thereof Pending 17-Mar-2021
AU-2022238294-A1 Compounds for the treatment of disorders and salts and polymorphs thereof Pending 17-Mar-2021
US-20240174598-A1 Compounds for the treatment of disorders and salts and polymorphs thereof Pending 17-Mar-2021
AU-2020901858-A0 Compounds and methods for the treatment of eye disorders Inactive 05-Jun-2020
To view OccuRx’s complete patent history, request access »

OccuRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OccuRx Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Biocatalyst Venture Capital Minority
Brandon Capital Venture Capital Minority
Certa Therapeutics Corporation Minority
Stoic Venture Capital Venture Capital Minority
Uniseed Venture Capital Minority
To view OccuRx’s complete investors history, request access »

OccuRx FAQs

  • When was OccuRx founded?

    OccuRx was founded in 2014.

  • Where is OccuRx headquartered?

    OccuRx is headquartered in Melbourne, Australia.

  • What is the size of OccuRx?

    OccuRx has 5 total employees.

  • What industry is OccuRx in?

    OccuRx’s primary industry is Biotechnology.

  • Is OccuRx a private or public company?

    OccuRx is a Private company.

  • What is OccuRx’s current revenue?

    The current revenue for OccuRx is .

  • How much funding has OccuRx raised over time?

    OccuRx has raised $15.3M.

  • Who are OccuRx’s investors?

    Brandon Biocatalyst, Brandon Capital, Certa Therapeutics, Stoic Venture Capital, and Uniseed have invested in OccuRx.

  • Who are OccuRx’s competitors?

    Clearside Biomedical, Adverum Biotechnologies, Beacon Therapeutics, Gradalis, and Rein Therapeutics are some of the 9 competitors of OccuRx.

  • When was OccuRx acquired?

    OccuRx was acquired on 19-Dec-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »